{
  "trial_id": "NCT00630825",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, body mass index (BMI), glycosylated hemoglobin (HbA1c) level, duration of Type 2 Diabetes Mellitus, use of oral antihyperglycemic medications, serum creatinine level, history of cardiovascular events, liver function tests (alanine transaminase), history of pancreatitis, pregnancy status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "glycosylated hemoglobin (HbA1c) level"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Duration of Diabetes",
          "duration of Type 2 Diabetes Mellitus"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "use of oral antihyperglycemic medications",
        "serum creatinine level",
        "history of cardiovascular events",
        "liver function tests (alanine transaminase)",
        "history of pancreatitis",
        "pregnancy status"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Concomitant Medications, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "Duration of Diabetes",
          "Duration of Diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "Concomitant Medications",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Fasting Plasma Glucose"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HbA1c, Diabetes duration, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "Duration of Diabetes",
          "Diabetes duration"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Fasting Plasma Glucose",
        "Total Cholesterol",
        "Triglycerides",
        "HDL Cholesterol",
        "LDL Cholesterol"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes mellitus, history of diabetes-related complications, current antihyperglycemic medications, glycosylated hemoglobin (HbA1c) at baseline, fasting plasma glucose at baseline, systolic and diastolic blood pressure, heart rate, waist circumference, lipid profile (total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "glycosylated hemoglobin (HbA1c) at baseline"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Duration of Diabetes",
          "duration of type 2 diabetes mellitus"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "history of diabetes-related complications",
        "current antihyperglycemic medications",
        "fasting plasma glucose at baseline",
        "systolic and diastolic blood pressure",
        "heart rate",
        "waist circumference",
        "lipid profile (total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides)"
      ]
    }
  }
}